Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer's Disease Trials. Ritchie M, Witbracht M, Nuno MM, Hoang D, et al. J Alzheimers Dis 2022 Oct 12. pii: JAD220801. doi: 10.3233/JAD-220801.

Read + Share

Amedeo Smart

Independent Medical Education

Ritchie M, Witbracht M, Nuno MM, Hoang D, et al. Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer's Disease Trials. J Alzheimers Dis 2022 Oct 12. pii: JAD220801. doi: 10.3233/JAD-220801.
PMID: 36245381